ADENOİDEKTOMİ YAPILAN HASTALARDA PLATELET-LENFOSİT ORANI

Platelet-to-lymphocyte Ratio in Diagnosis of Acute Complicated Appendicitis in Childhood Çocukluk Çaği Akut Kompli̇ke Apandi̇si̇t Tanisinda Platelet Lenfosi̇t Orani

DOI: 10.4328/JCAM.4873 Received: 27.11.2016 Accepted: 20.12.2016 Printed: 01.07.2017 J Clin Anal Med 2017;8(4): 299-301 Corresponding Author: Mervan Bekdas, Department of Pediatrics, Abant Izzet Baysal University Faculty of Medicine, Bolu, Turkey. E-Mail: [email protected] Öz Amaç: Akut komplike apandisit tanısının geç veya yanlış konulması morbidite ve mortaliteyi arttırabilmektedir. Bu çalış...

A Recursive Dynamic Computable General Equilibrium Model For Agricultural Policy Analysis in Spain ( ORANI - DYN ) . Part II : Modifications to the Standard ORANI - G model framework

Mitral Darlığı Olan Hastalarda Atriyal Elektiriksel ve Elektromekanik Özellikler ÖZET

Introduction: AF in patients with mitral stenosis (MS) causes significant morbidity and mortality. PMBV, which is a treatment of choice for patients with MS, is a highly successful procedure that provides significant improvement in symptoms and echocardiographic parameters. In this study we aimed to demonstrate the probable effects of PMBV on novel echocardiographic and electrocardiographic par...

Conversion from Platelet-Rich Plasma Platelet Production to Buffy Coat Platelet Component Production: Benefits and Limitations

Blood transfusion centers are under considerable pressure to produce platelet concentrates with high quality and safety due to the short shelf life of 3-5 days as well as possible bacterial and viral contaminations. For a variety of reasons, many Europeans have changed their methods of component production from whole blood using the North American standard platelet-rich plasma method to the buf...

Infusible Platelet Membrane versus Conventional Platelet Concentrate: Benefits and Disadvantages

Blood transfusion centers are under considerable pressure to produce platelet concentrates with a shelf life limit of 3 to 5 days. Many approaches have been investigated experimentally to produce new hemostatically active platelet products that are capable of long term storage. In this article infusible platelet membrane will be explained as a platelet substitute versus conventional liquid-stor...